CN111607571B - 一种特异性激活免疫共刺激通路的复制型溶瘤腺病毒及其制备方法和应用 - Google Patents
一种特异性激活免疫共刺激通路的复制型溶瘤腺病毒及其制备方法和应用 Download PDFInfo
- Publication number
- CN111607571B CN111607571B CN201910140498.4A CN201910140498A CN111607571B CN 111607571 B CN111607571 B CN 111607571B CN 201910140498 A CN201910140498 A CN 201910140498A CN 111607571 B CN111607571 B CN 111607571B
- Authority
- CN
- China
- Prior art keywords
- scd137l
- tumor
- cells
- virus
- cd137l
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10051—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910140498.4A CN111607571B (zh) | 2019-02-26 | 2019-02-26 | 一种特异性激活免疫共刺激通路的复制型溶瘤腺病毒及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910140498.4A CN111607571B (zh) | 2019-02-26 | 2019-02-26 | 一种特异性激活免疫共刺激通路的复制型溶瘤腺病毒及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111607571A CN111607571A (zh) | 2020-09-01 |
CN111607571B true CN111607571B (zh) | 2022-08-30 |
Family
ID=72202841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910140498.4A Active CN111607571B (zh) | 2019-02-26 | 2019-02-26 | 一种特异性激活免疫共刺激通路的复制型溶瘤腺病毒及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111607571B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112592901B (zh) * | 2020-12-15 | 2023-07-25 | 华中农业大学 | 构建表达焦亡蛋白的溶瘤腺相关病毒oAAV-SP-GSDM-NT的方法及其应用 |
CN114908064A (zh) * | 2021-02-09 | 2022-08-16 | 南京惟亚德生物医药有限公司 | 一种能抑制肿瘤进展并延长荷瘤个体生存时间的复制型溶瘤腺病毒及其应用 |
CN113980915B (zh) * | 2021-11-04 | 2023-07-07 | 江苏省人民医院(南京医科大学第一附属医院) | 一种新型的表达cxcl10的复制型溶瘤腺病毒和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100896483B1 (ko) * | 2007-07-13 | 2009-05-08 | 연세대학교 산학협력단 | Il-12 및 4-1bbl을 발현하는 종양 선택적 살상 재조합아데노바이러스 및 수지상 세포를 유효성분으로 포함하는항종양용 약제학적 조성물 |
CN102174522B (zh) * | 2011-02-24 | 2013-11-06 | 杭州师范大学 | 一种4-1bbl蛋白的制备方法 |
-
2019
- 2019-02-26 CN CN201910140498.4A patent/CN111607571B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111607571A (zh) | 2020-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110128550B (zh) | 一种新型的同时阻断免疫检查点pd-l1和tigit的复制型溶瘤腺病毒和应用 | |
CN105602992B (zh) | 一种基于复制缺陷性重组慢病毒的car-t转基因载体及其构建方法和应用 | |
CN109576231B (zh) | 分离的重组溶瘤腺病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 | |
CN111606999B (zh) | 兼具激活免疫共刺激信号通路和阻断免疫检查点的复制型溶瘤腺病毒及其应用 | |
CN111607571B (zh) | 一种特异性激活免疫共刺激通路的复制型溶瘤腺病毒及其制备方法和应用 | |
CN105949317B (zh) | 抗cd20嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用 | |
CN112533621A (zh) | 强化病毒疗法的基于细胞的媒介 | |
CN105949316B (zh) | 抗EGFRvIII嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用 | |
CN105820255B (zh) | 抗cd33嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用 | |
CN110462029A (zh) | 无预先免疫步骤的hiv免疫疗法 | |
CN105950664B (zh) | 一种靶向cd123的复制缺陷性重组慢病毒car-t转基因载体及其构建方法和应用 | |
CN107190013A (zh) | 一种以人Ad5复制缺陷型腺病毒为载体的寨卡病毒病疫苗 | |
CN110157686B (zh) | 一种免疫检查点激活免疫共刺激的复制型溶瘤腺病毒及其构建方法和应用 | |
CN108715856B (zh) | 一种以人复制缺陷腺病毒为载体的马尔堡病毒病疫苗 | |
CN109276580B (zh) | 一种用于治疗肿瘤的病毒 | |
CN102787097A (zh) | 经修饰的树突状细胞及包含该树突状细胞的疫苗 | |
CN103820483B (zh) | 表达α-gal表位的卵巢癌干细胞疫苗及其制备方法 | |
CN113248577B (zh) | 一种以腺病毒为载体的冠状病毒疫苗及其制备方法 | |
CN105969805B (zh) | 一种靶向Mesothelin的复制缺陷性重组慢病毒CAR-T转基因载体及其构建方法和应用 | |
CN115820742A (zh) | 一种提高nk细胞慢病毒转导效率的方法 | |
CN114344472A (zh) | 一种利用外源性抗原和治疗剂联合治疗肿瘤的方法 | |
CN106978397A (zh) | 一种人dc-cik免疫活性细胞及其制备方法 | |
CN117024605B (zh) | 嵌合抗原受体、表达嵌合抗原受体的小胶质细胞及其应用 | |
CN105002145B (zh) | 利用mTERT和mTyr双启动子联合调控HN基因构建重组腺病毒的方法及重组腺病毒和应用 | |
WO2021197506A1 (zh) | 重组新城疫病毒及制备方法、重组质粒、及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wei Jiwu Inventor after: Zhang Yonghui Inventor after: Wu Junhua Inventor after: Zhang Hailin Inventor after: Dong Jie Inventor before: Wei Jiwu Inventor before: Zhang Yonghui Inventor before: Zhang Hailin Inventor before: Wu Junhua Inventor before: Dong Jie |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210812 Address after: Room 1611, building a, phase I, Zhongdan Ecological Life Science Industrial Park, No. 3-1, xinjinhu Road, Jiangbei new area, Nanjing, Jiangsu 210000 Applicant after: Nanjing weiyade biomedical Co.,Ltd. Address before: 163 Xianlin Avenue, Qixia District, Nanjing City, Jiangsu Province Applicant before: NANJING University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |